Low-dose and heparin-free hemodialysis in children
- PMID: 2031839
- DOI: 10.1007/BF01095957
Low-dose and heparin-free hemodialysis in children
Abstract
Successful heparin-free hemodialysis has been reported in adults but not in children. A preliminary study was carried out to determine whether heparin-free hemodialysis was possible in children who were considered to have a high risk of bleeding, and if so, to identify the children in whom this technique might be expected to succeed. Of 28 heparin-free procedures, 21 (75%) were successful, a major clot developed in 4, and a minor clot occurred in 3. These children were 6.76 +/- 4.57 years old and weighed 20.7 +/- 11.3 kg. An activated clotting time (ACT) of less than 170 s was recorded in five of the six patients in whom clotting was observed (normal value 146 s with a range of 110-180 s). In a second prospective study, low-dose heparin was prescribed for patients with an ACT of less than 170 s, while the remaining children again underwent heparin-free dialysis. In this study only those patients with double-lumen vascular access and a predialysis systolic blood pressure greater than 80 mmHg were included. Their mean age was 12.25 +/- 4.61 years and their weights 32.9 +/- 19.3 Kg. In 28 of 31 (90%) procedures, no clotting was observed. Minor clotting developed during the remaining 3 procedures, all in one child who weighed 8.5 kg (the only child weighing less than 10 kg). Heparin (9.6 +/- 3.2 IU/kg body weight per hour) was administered during 18 successful procedures. This study shows that heparin-free hemodialysis is possible in children, particularly, but not exclusively, those with a coagulopathy.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Hemodialysis in infants and small children.Pediatr Nephrol. 1994 Feb;8(1):103-6. doi: 10.1007/BF00868283. Pediatr Nephrol. 1994. PMID: 8142206 Review.
-
Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.Kidney Int. 1996 Mar;49(3):806-13. doi: 10.1038/ki.1996.112. Kidney Int. 1996. PMID: 8648924 Clinical Trial.
-
Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.Am J Nephrol. 2002 Jan-Feb;22(1):58-66. doi: 10.1159/000046675. Am J Nephrol. 2002. PMID: 11919404 Clinical Trial.
-
Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding.Nephron Clin Pract. 2004;97(1):c5-10. doi: 10.1159/000077589. Nephron Clin Pract. 2004. PMID: 15153761
-
Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.Am J Kidney Dis. 2016 Nov;68(5):752-762. doi: 10.1053/j.ajkd.2016.05.013. Epub 2016 Jun 23. Am J Kidney Dis. 2016. PMID: 27344212 Clinical Trial.
Cited by
-
Critical care in uraemic children.Pediatr Nephrol. 1992 Jan;6(1):88-95. doi: 10.1007/BF00856850. Pediatr Nephrol. 1992. PMID: 1536749 Review.
-
Hemodialysis in infants and small children.Pediatr Nephrol. 1994 Feb;8(1):103-6. doi: 10.1007/BF00868283. Pediatr Nephrol. 1994. PMID: 8142206 Review.
-
Hemostatic complications in renal disorders of the young.Pediatr Nephrol. 1996 Feb;10(1):88-99. doi: 10.1007/BF00863459. Pediatr Nephrol. 1996. PMID: 8611369 Review.
-
Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments.Pediatr Nephrol. 2012 Oct;27(10):1869-79. doi: 10.1007/s00467-012-2129-5. Epub 2012 Feb 29. Pediatr Nephrol. 2012. PMID: 22374405 Free PMC article. Review.
-
Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.Pediatr Nephrol. 2022 Oct;37(10):2303-2330. doi: 10.1007/s00467-021-05020-z. Epub 2021 Oct 19. Pediatr Nephrol. 2022. PMID: 34668064
References
MeSH terms
Substances
LinkOut - more resources
Medical